Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 191

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

miR‐125b promotes growth of prostate cancer xenograft tumor through targeting pro‐apoptotic genes

Open access
Shi, Xu‐Bao, Xue, Lingru, Ma, Ai‐Hong, Tepper, Clifford G., Kung, Hsing‐Jien, White, Ralph W. deVere · 2011 · The Prostate

Abstract

BACKGROUND: Increasing evidence demonstrates that aberrantly regulated microRNAs (miRNAs) contribute to the initiation and progression of human cancer. We previously have demonstrated that miR‐125b stimulated the growth of prostate cancer (CaP) cells. In this study, we further determined the influence of miR‐125b on the pathogenesis of CaP. METHODS: To evaluate the effect of miR‐125b on xenograft tumor growth, male athymic mice were subcutaneously injected with PC‐346C‐miR‐125b cells that stably overexpressed miR‐125b. Potential direct target transcripts of miR‐125b were identified using a bioinformatics approach and three miR‐125b targeted molecules were confirmed by means of biochemical analyses. RESULTS: Enforced expression of miR‐125b promoted tumor growth in both intact and castrated male nude mice. In an effort to define the molecular mechanism(s) mediating its tumor growth properties, we found that miR‐125b directly targets eight transcripts, including three key pro‐apoptotic genes: p53, Puma, and Bak1. Increasing the abundance of miR‐125b resulted in a dramatic decrease in the levels of these three proteins in CaP cells. A direct repressive effect on each of these was supported by the ability of miR‐125b to significantly reduce the activity of luciferase reporters containing their 3′‐untranslated regions of each gene encompassing the miR‐125b‐binding sites. Additionally, we found that repression of miR‐125b activity was able to sensitize CaP cells to different therapeutic interventions. CONCLUSION: Data obtained in this study demonstrate that miR‐125b promotes growth of prostatic xenograft tumors by down‐regulating three key pro‐apoptotic genes. This suggests that miR‐125b is oncogenic and makes it an attractive therapeutic target in CaP. Prostate 77:538–549, 2011. © 2010 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pros.21270

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Shi, X., Xue, L., Ma, A., Tepper, C. G., Kung, H., & White, R. W. D.
Venue
The Prostate
Publisher
Wiley
Published
2010-09-30
Volume
71
Issue
5
Pages
538-549
ISSN
  • 0270-4137 (ISSN-L)
  • 1097-0045
OpenAlex
W2067012955
Cited by
191
References
3
FWCI
4.52
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.